Klimalife

Dosage form Application area Recommendations for use Contraindications Manufacturer
Read on
Certificate number:RU.77.99.88.003.E.000562.02.18
Date of registration and renewal:06.02.2018
Dosage form: & nbspCapsules №1 for 400 mg, capsules №2 for 400 mg, capsules №3 for 400 mg
Classification "Composition" & nbsp BAD - products of plant, animal or mineral origin
Classification "Clinical" & nbsp Supplements containing iron
Composition: & nbspCapsule number 1: maltodextrin or microcrystalline cellulose, extract of berries of saccharose vinex, green leaf tea extract, herbaceous leaves extract, ginseng root extract, vitamin B6 (pyridoxine hydrochloride), vitamin B1 (thiamine hydrochloride), calcium stearate, silicon amorphous dioxide, capsule (gelatin or cellulose ).
Capsule number 2: maltodextrin or microcrystalline cellulose, Peruvian poppy tuber extract, St. John's wort perfume extract, folic acid, calcium stearate, silicon amorphous dioxide, capsule (gelatin or cellulose).
Capsule number 3: maltodextrin or microcrystalline cellulose, iron sulfate, vitamin C (ascorbic acid), calcium carbonate, magnesium citrate, green tea leaf extract, vitamin E (DL-alpha-tocopherol acetate), vitamin A (retinol palmitate), vitamin D3 (cholecalciferol) , calcium stearate, silicon dioxide amorphous, capsule (gelatin or cellulose).
Scope: & nbspFor realization to the population as a biologically active additive to food - an additional source of vitamins (A, D3, E, C, B1, B6, folic acid) and iron, a source of panaxosides.
Suggested Usage: & nbspAdults take 1 capsule # 1, # 2, # 3 1 time per day with meals. Duration of admission is 2-3 weeks. If necessary, the reception can be repeated in a month.
Contraindications:Individual intolerance of components, pregnancy, breast-feeding, increased nervous excitability, insomnia, high blood pressure, irregular heart rhythm, pronounced atherosclerosis, reception in the evening. Before use, it is recommended to consult a doctor.
Shelf life:2 years.
Storage conditions:Store in a dry place inaccessible to children, at a temperature not exceeding 25 ° C.
Research protocols:Expert conclusion of the FBU of the Federal Target Program and the Federal Service for Consumer Rights Protection No. 10 FC / 220 dated January 31, 2013
Recipient:Hendel, OOOHendel, OOO Russian Federation
Information update date: & nbsp15.04.2018
Instructions
Up